Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

AstraZeneca plc

Start price
Target price
Perf. (%)
€94.00
22.09.20
€78.00
04.11.21
-0.76%
07.06.21

AstraZeneca plc

Start price
Target price
Perf. (%)
€94.00
22.09.20
€78.00
04.11.21
-0.76%
07.06.21

buy
Sorrento Therapeutics Inc.

Start price
Target price
Perf. (%)
€8.17
21.09.20
€12.00
02.11.20
-24.15%
02.11.20

Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Top 10 in its market
Leading role in innovation
buy
Sangamo Therapeutics Inc.

Start price
Target price
Perf. (%)
€8.92
20.09.20
-
04.11.21
6.78%
05.11.21

Could be worthwhile Investment >10% per year
Very low/no dividend yield expected
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€91.29
19.09.20
-
04.11.21
16.11%
27.11.20

Could be worthwhile Investment >10% per year
Future proof or reliable business model
buy
Immunomedics Inc.

Start price
Target price
Perf. (%)
€72.02
19.09.20
-
04.11.21
3.10%
05.11.21

Could be worthwhile Investment >10% per year
buy
Sorrento Therapeutics Inc.

Start price
Target price
Perf. (%)
€8.00
19.09.20
-
04.11.21
-26.89%
05.11.21

Could be worthwhile Investment >10% per year
buy
Vaxart Inc.

Start price
Target price
Perf. (%)
€4.22
09.09.20
€8.00
04.11.21
42.75%
05.11.21

Could be worthwhile Investment >10% per year
buy
Corbus Pharmaceuticals Holding Inc.

Start price
Target price
Perf. (%)
€47.63
08.09.20
-
19.09.20
-4.25%
19.09.20

Could be worthwhile Investment >10% per year
Very bad culture
No uniques
Below average Management
buy
Sorrento Therapeutics Inc.

Start price
Target price
Perf. (%)
€5.60
08.09.20
€7.00
21.09.20
46.07%
21.09.20

Could be very worthwhile Investment >20% year
Very Future proof/growth oriented business model
Top 10 in its market
Leading role in innovation
Trillium Therapeutics

Start price
Target price
Perf. (%)
€8.28
07.09.20
-
04.11.21
-21.91%
15.07.21

Could be very worthwhile Investment >20% year
buy
Eli Lilly Corp.

Start price
Target price
Perf. (%)
€128.00
06.09.20
€125.00
04.11.21
-3.25%
06.11.20

Future proof or reliable business model
Higher risks for its business
Risky Investment
buy
Verastem Inc.

Start price
Target price
Perf. (%)
€11.94
06.09.20
€24.00
28.09.20
7.41%
28.09.20

Could be very worthwhile Investment >20% year
Fair valuation
Increased challenges to pay loans and raise capital
Risky balance sheet
buy
Novavax Inc.

Start price
Target price
Perf. (%)
€80.99
05.09.20
-
04.11.21
74.71%
03.06.21

Could be very worthwhile Investment >20% year
buy
Grifols S.A.

Start price
Target price
Perf. (%)
€22.77
01.09.20
€30.00
04.11.21
-18.75%
05.11.21

Could be worthwhile Investment >10% per year
buy
Uniqure B.V.

Start price
Target price
Perf. (%)
€32.45
29.08.20
€40.00
04.11.21
-7.18%
05.11.21

Could be worthwhile Investment >10% per year
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€55.32
26.08.20
€50.00
08.10.20
-2.68%
08.10.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€55.32
26.08.20
€50.00
08.10.20
-2.68%
08.10.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Gilead Sciences Inc

Start price
Target price
Perf. (%)
€55.32
26.08.20
€50.00
08.10.20
-2.68%
08.10.20

Known brand
Fair valuation
Leading role in innovation
Future proof or reliable business model
Teligent Inc.

Start price
Target price
Perf. (%)
€1.05
26.08.20
-
02.09.20
-13.71%
02.09.20

buy
Verastem Inc.

Start price
Target price
Perf. (%)
€13.13
25.08.20
€25.20
04.11.21
120.37%
05.11.21

Could be worthwhile Investment >10% per year
Pfizer Inc.

Start price
Target price
Perf. (%)
€30.93
25.08.20
€25.62
03.09.20
-2.45%
03.09.20

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
Pfizer Inc.

Start price
Target price
Perf. (%)
€30.93
25.08.20
€25.62
03.09.20
-2.45%
03.09.20

Capable Management
Good culture
Innovative
Differentiated customer and product portfolio
buy
Amgen Inc.

Start price
Target price
Perf. (%)
€207.40
25.08.20
€225.00
21.09.20
-1.23%
21.09.20

Could be worthwhile Investment >10% per year
High dividend yield expected
positive Cash Flow expected
Good rating
buy
Amgen Inc.

Start price
Target price
Perf. (%)
€207.40
25.08.20
€225.00
21.09.20
-1.23%
21.09.20

Could be worthwhile Investment >10% per year
High dividend yield expected
positive Cash Flow expected
Good rating